Why the study?
Does daily ingestion of cranberry juice alter the pharmacokinetics or anticoagulant effect of warfarin, tizanidine, or midazolam in healthy volunteers?
Does daily ingestion of cranberry juice alter the pharmacokinetics or anticoagulant effect of warfarin, tizanidine, or midazolam in healthy volunteers?
Daily ingestion of cranberry juice does not inhibit CYP2C9, CYP1A2, or CYP3A4 activities, making a pharmacokinetic interaction with warfarin unlikely.
Answers are grounded in this paper and cite their sources.
No interaction with warfarin or CYP probes in healthy volunteers; leaves open effects in anticoagulated patients.
Case reports suggest that cranberry juice can increase the anticoagulant effect of warfarin. We investigated the effects of cranberry juice on R-S-warfarin, tizanidine, and midazolam; probes of CYP2C9, CYP1A2, and CYP3A4. Ten healthy volunteers took 200 ml cranberry juice or water t.i.d. for 10 days. On day 5, they ingested 10 mg racemic R-S-warfarin, 1 mg tizanidine, and 0.5 mg midazolam, with juice or water, followed by monitoring of drug concentrations and thromboplastin time. Cranberry juice did not increase the peak plasma concentration or area under concentration-time curve (AUC) of the probe drugs or their metabolites, but slightly decreased (7%; P=0.051) the AUC of S-warfarin. Cranberry juice did not change the anticoagulant effect of warfarin. Daily ingestion of cranberry juice does not inhibit the activities of CYP2C9, CYP1A2, or CYP3A4. A pharmacokinetic mechanism for the cranberry juice-warfarin interaction seems unlikely.
No takes yet. Share an insight, caveat, or question.
Lilja et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: